http://www.provigil-rx.info The Ultimate Provigil/Modafinil Information Resource - Aggregated & Updated Daily Fri, 03 Feb 2012 15:17:01 +0000 http://wordpress.org/?v=2.8.5 en hourly 1 http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNFv1OAjSCHz1qoBAa2hTIiwPSQ1QQ&url=http://business-standard.com/india/news/can-ranbaxy-recoverits-us-debacle/463468/ http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNFv1OAjSCHz1qoBAa2hTIiwPSQ1QQ&url=http://business-standard.com/india/news/can-ranbaxy-recoverits-us-debacle/463468/#comments Wed, 01 Feb 2012 18:31:06 +0000 admin tag:news.google.com,2005:cluster=http://business-standard.com/india/news/can-ranbaxy-recoverits-us-debacle/463468/

Can Ranbaxy recover from its US debacle?
Business Standard
“We expect it to be generic Provigil, Diovan and Valcyte contributing sales to the tune of $186 million,” Sushant Dalmia of Pinc Research stated. Takeda's $4.5 billion diabetes pill Actos, Astra Zeneca's $5 billion hurt burn drug Nexium and several ...

and more »

]]>

Can Ranbaxy recover from its US debacle?
Business Standard
“We expect it to be generic Provigil, Diovan and Valcyte contributing sales to the tune of $186 million,” Sushant Dalmia of Pinc Research stated. Takeda's $4.5 billion diabetes pill Actos, Astra Zeneca's $5 billion hurt burn drug Nexium and several ...

and more »

]]> http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNFv1OAjSCHz1qoBAa2hTIiwPSQ1QQ&url=http://business-standard.com/india/news/can-ranbaxy-recoverits-us-debacle/463468/feed/ 0 http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNEPtithCeBPNhwXoSMTgALyPbNRMQ&url=http://www.business-standard.com/india/news/can-ranbaxy-recoverits-us-debacle/463468/ http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNEPtithCeBPNhwXoSMTgALyPbNRMQ&url=http://www.business-standard.com/india/news/can-ranbaxy-recoverits-us-debacle/463468/#comments Wed, 01 Feb 2012 17:00:33 +0000 admin tag:news.google.com,2005:cluster=http://www.business-standard.com/india/news/can-ranbaxy-recoverits-us-debacle/463468/

Can Ranbaxy recover from its US debacle?
Business Standard
“We expect it to be generic Provigil, Diovan and Valcyte contributing sales to the tune of $186 million,” Sushant Dalmia of Pinc Research stated. Takeda's $4.5 billion diabetes pill Actos, Astra Zeneca's $5 billion hurt burn drug Nexium and several ...

and more »

]]>

Can Ranbaxy recover from its US debacle?
Business Standard
“We expect it to be generic Provigil, Diovan and Valcyte contributing sales to the tune of $186 million,” Sushant Dalmia of Pinc Research stated. Takeda's $4.5 billion diabetes pill Actos, Astra Zeneca's $5 billion hurt burn drug Nexium and several ...

and more »

]]> http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNEPtithCeBPNhwXoSMTgALyPbNRMQ&url=http://www.business-standard.com/india/news/can-ranbaxy-recoverits-us-debacle/463468/feed/ 0 http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNE__NF14LhuT7TWiI_VQXrP7fz-aw&url=http://forsal.pl/artykuly/588729,tanie_leki_z_indii_i_chin_moga_zalac_amerykanski_i_europejski_rynek.html http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNE__NF14LhuT7TWiI_VQXrP7fz-aw&url=http://forsal.pl/artykuly/588729,tanie_leki_z_indii_i_chin_moga_zalac_amerykanski_i_europejski_rynek.html#comments Sun, 29 Jan 2012 11:23:39 +0000 admin tag:news.google.com,2005:cluster=http://forsal.pl/artykuly/588729,tanie_leki_z_indii_i_chin_moga_zalac_amerykanski_i_europejski_rynek.html

Tanie leki z Indii i Chin mogą zalać amerykański i europejski rynek
Forsal.pl
W 2012 r. wyłączność w amerykańskich aptekach stracą też takie specyfiki jak Seroquel (firmy AstraZeneca), Lexapro (Lundbeck oraz Forest), Provigil (w Polsce znany pod nazwami Vigil lub Modafinil, produkowany przez koncern Teva), Singulair (Merck & Co ...

]]>

Tanie leki z Indii i Chin mogą zalać amerykański i europejski rynek
Forsal.pl
W 2012 r. wyłączność w amerykańskich aptekach stracą też takie specyfiki jak Seroquel (firmy AstraZeneca), Lexapro (Lundbeck oraz Forest), Provigil (w Polsce znany pod nazwami Vigil lub Modafinil, produkowany przez koncern Teva), Singulair (Merck & Co ...

]]> http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNE__NF14LhuT7TWiI_VQXrP7fz-aw&url=http://forsal.pl/artykuly/588729,tanie_leki_z_indii_i_chin_moga_zalac_amerykanski_i_europejski_rynek.html/feed/ 0 http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNHHW86PpiKjbHBIvg0ByzAGUE43Jg&url=http://www.enredando.org.ar/agencia.shtml?x%3D75115 http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNHHW86PpiKjbHBIvg0ByzAGUE43Jg&url=http://www.enredando.org.ar/agencia.shtml?x%3D75115#comments Sun, 29 Jan 2012 11:07:42 +0000 admin tag:news.google.com,2005:cluster=http://www.enredando.org.ar/agencia.shtml?x=75115

Voltaren ointment
enREDando.org.ar
... oZbuQUQ, [url=http://viagra-guide.com/]Viagra online without prescription[/url], GKEREEL, http://viagra-guide.com/ Viagra increases penis size, wWoQiam, Dystymia provigil, QPEEgdy, [url=http://www.promotewakefulness.com/]Provigil[/url], NSjEFOk, ...

and more »

]]>

Voltaren ointment
enREDando.org.ar
... oZbuQUQ, [url=http://viagra-guide.com/]Viagra online without prescription[/url], GKEREEL, http://viagra-guide.com/ Viagra increases penis size, wWoQiam, Dystymia provigil, QPEEgdy, [url=http://www.promotewakefulness.com/]Provigil[/url], NSjEFOk, ...

and more »

]]> http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNHHW86PpiKjbHBIvg0ByzAGUE43Jg&url=http://www.enredando.org.ar/agencia.shtml?x%3D75115/feed/ 0 http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNHhUN9kUdq7sHkVkn6TVHitU6xiow&url=http://economictimes.indiatimes.com/markets/stocks/stocks-in-news/ranbaxy-falls-7-to-nine-month-low-on-usfda-settlement-costs/articleshow/11657842.cms http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNHhUN9kUdq7sHkVkn6TVHitU6xiow&url=http://economictimes.indiatimes.com/markets/stocks/stocks-in-news/ranbaxy-falls-7-to-nine-month-low-on-usfda-settlement-costs/articleshow/11657842.cms#comments Fri, 27 Jan 2012 22:05:27 +0000 admin tag:news.google.com,2005:cluster=http://economictimes.indiatimes.com/markets/stocks/stocks-in-news/ranbaxy-falls-7-to-nine-month-low-on-usfda-settlement-costs/articleshow/11657842.cms
IBNLive.com

Ranbaxy falls 7% to nine-month low on USFDA settlement costs
Economic Times
"We think Ranbaxy has lost first to file (FTF) status on products slated for launch in the near term: Actos (August 2012), Clarinex 5 mg (July 2012 launch) and Provigil (April 2012) or Diovan (March 2012)," she wrote in a note. Selling generic Actos in ...
Don't get excited about pharma cos with USFDA issues: IIFLMoneycontrol.com
Nexium, Actos, or Diovan? Analysts try to ID Ranbaxy's 3 sacrificesFiercePharma

all 8 news articles »

]]>
IBNLive.com

Ranbaxy falls 7% to nine-month low on USFDA settlement costs
Economic Times
"We think Ranbaxy has lost first to file (FTF) status on products slated for launch in the near term: Actos (August 2012), Clarinex 5 mg (July 2012 launch) and Provigil (April 2012) or Diovan (March 2012)," she wrote in a note. Selling generic Actos in ...
Don't get excited about pharma cos with USFDA issues: IIFLMoneycontrol.com
Nexium, Actos, or Diovan? Analysts try to ID Ranbaxy's 3 sacrificesFiercePharma

all 8 news articles »

]]> http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNHhUN9kUdq7sHkVkn6TVHitU6xiow&url=http://economictimes.indiatimes.com/markets/stocks/stocks-in-news/ranbaxy-falls-7-to-nine-month-low-on-usfda-settlement-costs/articleshow/11657842.cms/feed/ 0 http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNHUmSHpkksNIEOMybA-6R06uaHFMQ&url=http://www.business-standard.com/india/news/share-market-analysts-give-ranbaxythumbs-down/463030/ http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNHUmSHpkksNIEOMybA-6R06uaHFMQ&url=http://www.business-standard.com/india/news/share-market-analysts-give-ranbaxythumbs-down/463030/#comments Fri, 27 Jan 2012 17:40:17 +0000 admin tag:news.google.com,2005:cluster=http://www.business-standard.com/india/news/share-market-analysts-give-ranbaxythumbs-down/463030/
Business Today

Share market, analysts give Ranbaxy a thumbs down
Business Standard
Cephalon's sleep disorder drug, Provigil, and Novartis' blood pressure drug, Diovan, were also among the speculative list of exclusive marketing opportunities at risk. “We expect it to be generic Provigil, Diovan and Valcyte, contributing sales of $186 ...
Ranbaxy falls 7% to nine-month low on USFDA settlement costsEconomic Times
Ranbaxy Falls Most Since March on Settlement Costs: Mumbai MoverBusinessWeek
Ranbaxy scrip tanks 7% on 'harsh settlement' in USTimes of India
Calcutta Telegraph -Hindu Business Line
all 154 news articles »

]]>
Business Today

Share market, analysts give Ranbaxy a thumbs down
Business Standard
Cephalon's sleep disorder drug, Provigil, and Novartis' blood pressure drug, Diovan, were also among the speculative list of exclusive marketing opportunities at risk. “We expect it to be generic Provigil, Diovan and Valcyte, contributing sales of $186 ...
Ranbaxy falls 7% to nine-month low on USFDA settlement costsEconomic Times
Ranbaxy Falls Most Since March on Settlement Costs: Mumbai MoverBusinessWeek
Ranbaxy scrip tanks 7% on 'harsh settlement' in USTimes of India
Calcutta Telegraph -Hindu Business Line
all 154 news articles »

]]> http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNHUmSHpkksNIEOMybA-6R06uaHFMQ&url=http://www.business-standard.com/india/news/share-market-analysts-give-ranbaxythumbs-down/463030/feed/ 0 http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNEGidKslCaCuGtRzR9iZSWOjUrA_A&url=http://www.fiercepharma.com/story/nexium-actos-or-diovan-analysts-try-id-ranbaxys-3-sacrifices/2012-01-27 http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNEGidKslCaCuGtRzR9iZSWOjUrA_A&url=http://www.fiercepharma.com/story/nexium-actos-or-diovan-analysts-try-id-ranbaxys-3-sacrifices/2012-01-27#comments Fri, 27 Jan 2012 17:01:29 +0000 admin tag:news.google.com,2005:cluster=http://www.fiercepharma.com/story/nexium-actos-or-diovan-analysts-try-id-ranbaxys-3-sacrifices/2012-01-27

Nexium, Actos, or Diovan? Analysts try to ID Ranbaxy's 3 sacrifices
FiercePharma
Nomura Holdings identified the Cephalon ($CEPH) wakefulness drug Provigil, with $1.1 billion in US sales in 2010; the Takeda Pharmaceuticals ($TKPHF) diabetes pill Actos, with $3.35 billion; and the Novartis ($NVS) blood-pressure remedy Diovan, ...

]]>

Nexium, Actos, or Diovan? Analysts try to ID Ranbaxy's 3 sacrifices
FiercePharma
Nomura Holdings identified the Cephalon ($CEPH) wakefulness drug Provigil, with $1.1 billion in US sales in 2010; the Takeda Pharmaceuticals ($TKPHF) diabetes pill Actos, with $3.35 billion; and the Novartis ($NVS) blood-pressure remedy Diovan, ...

]]> http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNEGidKslCaCuGtRzR9iZSWOjUrA_A&url=http://www.fiercepharma.com/story/nexium-actos-or-diovan-analysts-try-id-ranbaxys-3-sacrifices/2012-01-27/feed/ 0 http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNFZDlXuZZN5fSeQyT-IKgHeRaTytg&url=http://www.thehindubusinessline.com/companies/article2837442.ece?ref%3Dwl_opinion http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNFZDlXuZZN5fSeQyT-IKgHeRaTytg&url=http://www.thehindubusinessline.com/companies/article2837442.ece?ref%3Dwl_opinion#comments Fri, 27 Jan 2012 16:13:14 +0000 admin tag:news.google.com,2005:cluster=http://www.thehindubusinessline.com/companies/article2837442.ece?ref=wl_opinion
Hindu Business Line

Ranbaxy: The long and winding road to salvation
Hindu Business Line
... 2010 (off patent in September 2012), the sleep disorder drug Provigil, which has a $1.1-billion sales in 2010 and AstraZeneca's heart-burn treatment drug Nexium that had an annual sales of $5.2 billion in 2010 (expected to be launched in May 2014).
Sell Ranbaxy Labs; target of Rs 355: PINC ResearchMoneycontrol.com

all 139 news articles »

]]>
Hindu Business Line

Ranbaxy: The long and winding road to salvation
Hindu Business Line
... 2010 (off patent in September 2012), the sleep disorder drug Provigil, which has a $1.1-billion sales in 2010 and AstraZeneca's heart-burn treatment drug Nexium that had an annual sales of $5.2 billion in 2010 (expected to be launched in May 2014).
Sell Ranbaxy Labs; target of Rs 355: PINC ResearchMoneycontrol.com

all 139 news articles »

]]> http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNFZDlXuZZN5fSeQyT-IKgHeRaTytg&url=http://www.thehindubusinessline.com/companies/article2837442.ece?ref%3Dwl_opinion/feed/ 0 http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNHVFGL70Iwa_aaePUdaA6nmuOUsUg&url=http://www.bloomberg.com/news/2012-01-27/ranbaxy-may-forgo-200-million-in-lost-sales-after-settlement-kotak-says.html http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNHVFGL70Iwa_aaePUdaA6nmuOUsUg&url=http://www.bloomberg.com/news/2012-01-27/ranbaxy-may-forgo-200-million-in-lost-sales-after-settlement-kotak-says.html#comments Fri, 27 Jan 2012 12:18:50 +0000 admin
Bloomberg

Ranbaxy Falls Most Since March on Proposed Settlement Costs: Mumbai Mover
Bloomberg
Provigil, Diovan Near-term exclusivities relate to versions of the sleep- disorder drug Provigil, which had $1.1 billion in sales in 2010; Actos; and Diovan, a blood-pressure pill made by Novartis AG (NOVN) that generated $1.5 billion in annual sales, ...
Share market, analysts give Ranbaxy a thumbs downBusiness Standard
Ranbaxy falls 7% to nine-month low on USFDA settlement costsEconomic Times
Tough US strictures on RanbaxyCalcutta Telegraph
Times of India -Hindu Business Line
all 154 news articles »

]]>
Bloomberg

Ranbaxy Falls Most Since March on Proposed Settlement Costs: Mumbai Mover
Bloomberg
Provigil, Diovan Near-term exclusivities relate to versions of the sleep- disorder drug Provigil, which had $1.1 billion in sales in 2010; Actos; and Diovan, a blood-pressure pill made by Novartis AG (NOVN) that generated $1.5 billion in annual sales, ...
Share market, analysts give Ranbaxy a thumbs downBusiness Standard
Ranbaxy falls 7% to nine-month low on USFDA settlement costsEconomic Times
Tough US strictures on RanbaxyCalcutta Telegraph
Times of India -Hindu Business Line
all 154 news articles »

]]> http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNHVFGL70Iwa_aaePUdaA6nmuOUsUg&url=http://www.bloomberg.com/news/2012-01-27/ranbaxy-may-forgo-200-million-in-lost-sales-after-settlement-kotak-says.html/feed/ 0 http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNHVFGL70Iwa_aaePUdaA6nmuOUsUg&url=http://www.bloomberg.com/news/2012-01-27/ranbaxy-may-forgo-200-million-in-lost-sales-after-settlement-kotak-says.html http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNHVFGL70Iwa_aaePUdaA6nmuOUsUg&url=http://www.bloomberg.com/news/2012-01-27/ranbaxy-may-forgo-200-million-in-lost-sales-after-settlement-kotak-says.html#comments Fri, 27 Jan 2012 12:18:50 +0000 admin tag:news.google.com,2005:cluster=http://www.bloomberg.com/news/2012-01-27/ranbaxy-may-forgo-200-million-in-lost-sales-after-settlement-kotak-says.html
Bloomberg

Ranbaxy Falls Most Since March on Proposed Settlement Costs: Mumbai Mover
Bloomberg
Provigil, Diovan Near-term exclusivities relate to versions of the sleep- disorder drug Provigil, which had $1.1 billion in sales in 2010; Actos; and Diovan, a blood-pressure pill made by Novartis AG (NOVN) that generated $1.5 billion in annual sales, ...
Share market, analysts give Ranbaxy a thumbs downBusiness Standard
Ranbaxy falls 7% to nine-month low on USFDA settlement costsEconomic Times
Ranbaxy scrip tanks 7% on 'harsh settlement' in USTimes of India
Calcutta Telegraph -Hindu Business Line
all 154 news articles »

]]>
Bloomberg

Ranbaxy Falls Most Since March on Proposed Settlement Costs: Mumbai Mover
Bloomberg
Provigil, Diovan Near-term exclusivities relate to versions of the sleep- disorder drug Provigil, which had $1.1 billion in sales in 2010; Actos; and Diovan, a blood-pressure pill made by Novartis AG (NOVN) that generated $1.5 billion in annual sales, ...
Share market, analysts give Ranbaxy a thumbs downBusiness Standard
Ranbaxy falls 7% to nine-month low on USFDA settlement costsEconomic Times
Ranbaxy scrip tanks 7% on 'harsh settlement' in USTimes of India
Calcutta Telegraph -Hindu Business Line
all 154 news articles »

]]> http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNHVFGL70Iwa_aaePUdaA6nmuOUsUg&url=http://www.bloomberg.com/news/2012-01-27/ranbaxy-may-forgo-200-million-in-lost-sales-after-settlement-kotak-says.html/feed/ 0